Biomakers
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- $8M
Investors
- 6
About Biomakers
Based in the US, and founded in 2014 by Nicolás Kirchuk, and Rubén Salanova, Biomakers, Inc. provides personalized cancer treatment by defining medical interventions based on genomic alterations found in patients' tumours.In January 2026, Biomakers, Inc. Biomakers offer a genomic information production platform for genomic testing services, ensuring quick access to the best treatments available. The company uses various techniques such as immunohistochemistry, fluorescence in situ hybridization (FISH), real-time PCR, digital PCR, and next-generation sequencing (NGS) for testing. By leveraging advanced technology and artificial intelligence, tests analyze specific genetic alterations and protein expressions in tumour samples, providing valuable insights into the behaviour of the tumour and predicting its response to specific therapies. The company offers a wide range of biomarker tests, such as tumour panel tests, including lung, colorectal, breast, sarcoma, and central nervous system panels, among others, that help diagnose and guide personalized treatment for various types of cancer. Biomaker SA generates revenue from genomic and molecular diagnostic testing, precision oncology services, biomarker analysis, bioinformatics platforms, and data-driven research collaborations.
Who invested in Biomakers
6 investors across 1 round
See all investors in Biomakers
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 12, 2026
Amount
$8M
Investors
Questions about Biomakers
Who invested in Biomakers?
Biomakers has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biomakers raised?
Biomakers has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Biomakers last raise money?
Biomakers's most recent round on record is a Series A, in Jan 2026.
What does Biomakers do?
Based in the US, and founded in 2014 by Nicolás Kirchuk, and Rubén Salanova, Biomakers, Inc.
Where is Biomakers headquartered?
Biomakers is headquartered in San Francisco, US.
Which VCs invest in companies like Biomakers?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Biomakers's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Biomakers? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.